Drug information for EPIRUBICIN HYDROCHLORIDE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
200MG/100ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
BEDFORD
65289
INJECTABLE; INJECTION
50MG/25ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
BEDFORD
"
INJECTABLE; INJECTION
200MG/100ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
TEVA PARENTERAL
65331
INJECTABLE; INJECTION
50MG/25ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
TEVA PARENTERAL
"
INJECTABLE; INJECTION
200MG/100ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
EBEWE PHARMA
65339
INJECTABLE; INJECTION
50MG/25ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
EBEWE PHARMA
"
INJECTABLE; INJECTION
10MG/5ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
HOSPIRA
65343
INJECTABLE; INJECTION
150MG/75ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
HOSPIRA
"
INJECTABLE; INJECTION
200MG/100ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
HOSPIRA
"
INJECTABLE; INJECTION
50MG/25ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
HOSPIRA
"
INJECTABLE; INJECTION
200MG/100ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
CIPLA LTD
65361
INJECTABLE; INJECTION
50MG/25ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
CIPLA LTD
"
INJECTABLE; INJECTION
200MG/100ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
BIONICHE PHARMA USA
65371
INJECTABLE; INJECTION
50MG/25ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
BIONICHE PHARMA USA
"
INJECTABLE; INJECTION
10MG/5ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
APP PHARMS
65408
INJECTABLE; INJECTION
150MG/75ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
APP PHARMS
"
INJECTABLE; INJECTION
200MG/100ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
APP PHARMS
"
INJECTABLE; INJECTION
50MG/25ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
APP PHARMS
"
INJECTABLE; INJECTION
200MG/100ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
FRESENIUS KABI ONCOL
65411
INJECTABLE; INJECTION
50MG/25ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
FRESENIUS KABI ONCOL
"
INJECTABLE; INJECTION
10MG/5ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
ACTAVIS TOTOWA
65445
INJECTABLE; INJECTION
200MG/100ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
ACTAVIS TOTOWA
"
INJECTABLE; INJECTION
50MG/25ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
ACTAVIS TOTOWA
"
INJECTABLE; INJECTION
200MG/100ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
HISUN PHARM HANGZHOU
90075
2010-04-04 Label
INJECTABLE; INJECTION
50MG/25ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
HISUN PHARM HANGZHOU
"
INJECTABLE; INJECTION
50MG/25ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
AKORN INC
90163
INJECTABLE; INJECTION
200MG/100ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
MUSTAFA NEVSAT
90266
INJECTABLE; INJECTION
50MG/25ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
MUSTAFA NEVSAT
"
INJECTABLE; INJECTION
200MG/100ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
ONCO THERAPIES LTD
91599
INJECTABLE; INJECTION
50MG/25ML (2MG/ML)
Prescription
AP
EPIRUBICIN HYDROCHLORIDE
Epirubicin
ONCO THERAPIES LTD
"
INJECTABLE; IV (INFUSION)
200MG/VIAL
Discontinued
EPIRUBICIN HYDROCHLORIDE
Epirubicin
HOSPIRA
50807
2008-10-01 Summary Review
2008-10-01 Review
2006-09-20 Letter
2006-09-18 Label
INJECTABLE; IV (INFUSION)
50MG/VIAL
Prescription
(Reference Drug)
EPIRUBICIN HYDROCHLORIDE
Epirubicin
HOSPIRA
"
Drug Adverse Effects information for EPIRUBICIN HYDROCHLORIDE
Role code
Indications
Reaction
# Reports
PS
ADJUVANT THERAPY
EXTRAVASATION
2
PS
ADJUVANT THERAPY
SKIN NECROSIS
4
PS
ADJUVANT THERAPY
STEVENS-JOHNSON SYNDROME
3
PS
ANTIEMETIC SUPPORTIVE CARE
DECREASED APPETITE
3
PS
ANTIEMETIC SUPPORTIVE CARE
MALAISE
3
PS
ANTIEMETIC SUPPORTIVE CARE
NEUTROPENIA
3
PS
ANTIEMETIC SUPPORTIVE CARE
PYREXIA
3
PS
ANTIEMETIC SUPPORTIVE CARE
WHITE BLOOD CELL COUNT DECREASED
3
PS
APPETITE DISORDER
SEPSIS
1
PS
APPETITE DISORDER
SEPSIS SYNDROME
1
PS
BLADDER CANCER
INTERSTITIAL LUNG DISEASE
1
PS
BREAST CANCER
BACTERAEMIA
2
PS
BREAST CANCER
BLOOD ALBUMIN DECREASED
1
PS
BREAST CANCER
CHOKING SENSATION
1
PS
BREAST CANCER
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
1
PS
BREAST CANCER
CONSTIPATION
3
PS
BREAST CANCER
DECREASED APPETITE
3
PS
BREAST CANCER
DEHYDRATION
1
PS
BREAST CANCER
DYSPHAGIA
1
PS
BREAST CANCER
FAILURE TO THRIVE
2
PS
BREAST CANCER
FEBRILE NEUTROPENIA
12
PS
BREAST CANCER
GENERAL PHYSICAL CONDITION ABNORMAL
1
PS
BREAST CANCER
HAEMATEMESIS
2
PS
BREAST CANCER
HERPES SIMPLEX
9
PS
BREAST CANCER
INTERSTITIAL LUNG DISEASE
10
PS
BREAST CANCER
LARYNGEAL OEDEMA
2
PS
BREAST CANCER
MALAISE
2
PS
BREAST CANCER
MUCOSAL INFLAMMATION
2
PS
BREAST CANCER
NAUSEA
9
PS
BREAST CANCER
NEUTROPENIA
8
PS
BREAST CANCER
OEDEMA PERIPHERAL
1
PS
BREAST CANCER
OESOPHAGITIS
9
PS
BREAST CANCER
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME
1
PS
BREAST CANCER
PARAESTHESIA
1
PS
BREAST CANCER
PNEUMONIA
1
PS
BREAST CANCER
PNEUMONIA ASPIRATION
2
PS
BREAST CANCER
PULMONARY EMBOLISM
2
PS
BREAST CANCER
PYREXIA
3
PS
BREAST CANCER
SHUNT OCCLUSION
2
PS
BREAST CANCER
STOMATITIS
3
PS
BREAST CANCER
THROMBOCYTOPENIA
2
PS
BREAST CANCER
VOMITING
9
PS
BREAST CANCER
WEIGHT DECREASED
9
PS
BREAST CANCER
WHITE BLOOD CELL COUNT DECREASED
2
PS
BREAST CANCER RECURRENT
FEBRILE NEUTROPENIA
1
PS
BREAST CANCER RECURRENT
HYPERNATRAEMIA
1
PS
BREAST CANCER RECURRENT
MALAISE
1
PS
BREAST CANCER RECURRENT
NEOPLASM MALIGNANT
1
PS
BREAST CANCER RECURRENT
SEPTIC SHOCK
1
PS
CONSTIPATION
ABDOMINAL PAIN
3
PS
CONSTIPATION
BACTERAEMIA
4
PS
CONSTIPATION
HAEMORRHAGIC ASCITES
4
PS
CONSTIPATION
INTESTINAL OBSTRUCTION
2
PS
CONSTIPATION
LIVER CARCINOMA RUPTURED
2
PS
CONSTIPATION
METASTASES TO PERITONEUM
2
PS
CONSTIPATION
NEUTROPENIA
4
PS
CONSTIPATION
PNEUMONIA ASPIRATION
1
PS
CONSTIPATION
PULMONARY EMBOLISM
1
PS
CONSTIPATION
SEPSIS
2
PS
CONSTIPATION
SEPSIS SYNDROME
2
PS
CONSTIPATION
THROMBOCYTOPENIA
4
PS
CONSTIPATION
WHITE BLOOD CELL COUNT DECREASED
4
PS
DEHYDRATION
ABDOMINAL PAIN
3
PS
DEHYDRATION
BACTERAEMIA
4
PS
DEHYDRATION
INTESTINAL OBSTRUCTION
2
PS
DEHYDRATION
NEUTROPENIA
4
PS
DEHYDRATION
THROMBOCYTOPENIA
4
PS
DEHYDRATION
WHITE BLOOD CELL COUNT DECREASED
4
PS
GALLBLADDER CANCER METASTATIC
ABDOMINAL PAIN
2
PS
GALLBLADDER CANCER METASTATIC
BACTERAEMIA
2
PS
GALLBLADDER CANCER METASTATIC
INTESTINAL OBSTRUCTION
2
PS
GALLBLADDER CANCER METASTATIC
NEUTROPENIA
2
PS
GALLBLADDER CANCER METASTATIC
THROMBOCYTOPENIA
2
PS
GALLBLADDER CANCER METASTATIC
WHITE BLOOD CELL COUNT DECREASED
2
PS
GASTRITIS PROPHYLAXIS
HAEMORRHAGIC ASCITES
2
PS
GASTRITIS PROPHYLAXIS
LIVER CARCINOMA RUPTURED
1
PS
GASTRITIS PROPHYLAXIS
METASTASES TO PERITONEUM
1
PS
HEADACHE
PNEUMONIA ASPIRATION
1
PS
HEADACHE
PULMONARY EMBOLISM
1
PS
HEPATIC CIRRHOSIS
CLOSTRIDIAL INFECTION
2
PS
HEPATIC CIRRHOSIS
LIVER ABSCESS
2
PS
HEPATIC NEOPLASM MALIGNANT
CLOSTRIDIAL INFECTION
2
PS
HEPATIC NEOPLASM MALIGNANT
HAEMORRHAGIC ASCITES
6
PS
HEPATIC NEOPLASM MALIGNANT
LIVER ABSCESS
2
PS
HEPATIC NEOPLASM MALIGNANT
LIVER CARCINOMA RUPTURED
3
PS
HEPATIC NEOPLASM MALIGNANT
METASTASES TO PERITONEUM
3
PS
HEPATIC NEOPLASM MALIGNANT
RENAL FAILURE ACUTE
3
PS
HEPATIC NEOPLASM MALIGNANT
TUMOUR LYSIS SYNDROME
3
PS
HYPERAMMONAEMIA
HAEMORRHAGIC ASCITES
2
PS
HYPERAMMONAEMIA
LIVER CARCINOMA RUPTURED
1
PS
HYPERAMMONAEMIA
METASTASES TO PERITONEUM
1
PS
HYPERTENSION
ABDOMINAL PAIN
3
PS
HYPERTENSION
BACTERAEMIA
4
PS
HYPERTENSION
HAEMORRHAGIC ASCITES
2
PS
HYPERTENSION
INTESTINAL OBSTRUCTION
2
PS
HYPERTENSION
LEUKOPENIA
2
PS
HYPERTENSION
LIVER CARCINOMA RUPTURED
1
PS
HYPERTENSION
METASTASES TO PERITONEUM
1
PS
HYPERTENSION
NEUTROPENIA
6
PS
HYPERTENSION
PULMONARY EMBOLISM
2
PS
HYPERTENSION
THROMBOCYTOPENIA
4
PS
HYPERTENSION
WHITE BLOOD CELL COUNT DECREASED
4
PS
INSOMNIA
ABDOMINAL PAIN
3
PS
INSOMNIA
BACTERAEMIA
4
PS
INSOMNIA
HAEMORRHAGIC ASCITES
2
PS
INSOMNIA
INTESTINAL OBSTRUCTION
2
PS
INSOMNIA
LIVER CARCINOMA RUPTURED
1
PS
INSOMNIA
METASTASES TO PERITONEUM
1
PS
INSOMNIA
NEUTROPENIA
4
PS
INSOMNIA
THROMBOCYTOPENIA
4
PS
INSOMNIA
WHITE BLOOD CELL COUNT DECREASED
4
PS
METASTASES TO LIVER
SEPTIC SHOCK
1
PS
METASTASES TO LUNG
SEPTIC SHOCK
1
PS
METASTATIC PAIN
SEPSIS
2
PS
METASTATIC PAIN
SEPSIS SYNDROME
2
PS
MUSCLE SPASMS
HAEMORRHAGIC ASCITES
4
PS
MUSCLE SPASMS
LIVER CARCINOMA RUPTURED
2
PS
MUSCLE SPASMS
METASTASES TO PERITONEUM
2
PS
NAUSEA
ABDOMINAL PAIN
3
PS
NAUSEA
BACTERAEMIA
4
PS
NAUSEA
INTESTINAL OBSTRUCTION
2
PS
NAUSEA
LEUKOPENIA
3
PS
NAUSEA
NEUTROPENIA
7
PS
NAUSEA
PNEUMONIA ASPIRATION
1
PS
NAUSEA
PULMONARY EMBOLISM
4
PS
NAUSEA
THROMBOCYTOPENIA
4
PS
NAUSEA
WHITE BLOOD CELL COUNT DECREASED
4
PS
NEUTROPENIA
ABDOMINAL PAIN
3
PS
NEUTROPENIA
BACTERAEMIA
4
PS
NEUTROPENIA
FEBRILE NEUTROPENIA
1
PS
NEUTROPENIA
HYPERNATRAEMIA
1
PS
NEUTROPENIA
INTESTINAL OBSTRUCTION
2
PS
NEUTROPENIA
MALAISE
1
PS
NEUTROPENIA
NEOPLASM MALIGNANT
1
PS
NEUTROPENIA
NEUTROPENIA
4
PS
NEUTROPENIA
THROMBOCYTOPENIA
4
PS
NEUTROPENIA
WHITE BLOOD CELL COUNT DECREASED
4
PS
NON-SMALL CELL LUNG CANCER
SEPSIS
2
PS
NON-SMALL CELL LUNG CANCER
SEPSIS SYNDROME
2
PS
OESOPHAGEAL ADENOCARCINOMA
AIR EMBOLISM
3
PS
OESOPHAGEAL ADENOCARCINOMA
BRAIN OEDEMA
3
PS
OESOPHAGEAL ADENOCARCINOMA
CONFUSIONAL STATE
3
PS
OESOPHAGEAL ADENOCARCINOMA
FAT EMBOLISM
3
PS
OESOPHAGEAL ADENOCARCINOMA
FISTULA
3
PS
OESOPHAGEAL ADENOCARCINOMA
GASTROINTESTINAL INJURY
3
PS
OESOPHAGEAL ADENOCARCINOMA
GASTROINTESTINAL TOXICITY
3
PS
OESOPHAGEAL ADENOCARCINOMA
GRAND MAL CONVULSION
3
PS
OESOPHAGEAL ADENOCARCINOMA
HAEMATEMESIS
3
PS
OESOPHAGEAL ADENOCARCINOMA
HEART INJURY
3
PS
OESOPHAGEAL ADENOCARCINOMA
IATROGENIC INJURY
3
PS
OESOPHAGEAL ADENOCARCINOMA
INTRACRANIAL PRESSURE INCREASED
3
PS
OESOPHAGEAL ADENOCARCINOMA
MENTAL STATUS CHANGES
3
PS
OESOPHAGEAL ADENOCARCINOMA
NAUSEA
3
PS
OESOPHAGEAL ADENOCARCINOMA
NEUROLOGICAL DECOMPENSATION
3
PS
OESOPHAGEAL ADENOCARCINOMA
PYREXIA
3
PS
OESOPHAGEAL ADENOCARCINOMA
VOMITING
3
PS
PAIN
ABDOMINAL PAIN
9
PS
PAIN
BACTERAEMIA
12
PS
PAIN
INTESTINAL OBSTRUCTION
6
PS
PAIN
LEUKOPENIA
1
PS
PAIN
NEUTROPENIA
13
PS
PAIN
PULMONARY EMBOLISM
1
PS
PAIN
RENAL FAILURE ACUTE
1
PS
PAIN
THROMBOCYTOPENIA
12
PS
PAIN
TUMOUR LYSIS SYNDROME
1
PS
PAIN
WHITE BLOOD CELL COUNT DECREASED
12
PS
PORTAL HYPERTENSION
HAEMORRHAGIC ASCITES
2
PS
PORTAL HYPERTENSION
LIVER CARCINOMA RUPTURED
1
PS
PORTAL HYPERTENSION
METASTASES TO PERITONEUM
1
PS
PREMEDICATION
SEPSIS
1
PS
PREMEDICATION
SEPSIS SYNDROME
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
CONDITION AGGRAVATED
3
PS
PRODUCT USED FOR UNKNOWN INDICATION
CONVULSION
3
PS
PROPHYLAXIS
HAEMATEMESIS
1
PS
PROPHYLAXIS
THROMBOCYTOPENIA
1
PS
PYREXIA
RENAL FAILURE ACUTE
1
PS
PYREXIA
TUMOUR LYSIS SYNDROME
1
PS
SINUS CONGESTION
PNEUMONIA ASPIRATION
1
PS
SINUS CONGESTION
PULMONARY EMBOLISM
1
PS
SUPPLEMENTATION THERAPY
ABDOMINAL PAIN
3
PS
SUPPLEMENTATION THERAPY
BACTERAEMIA
4
PS
SUPPLEMENTATION THERAPY
INTESTINAL OBSTRUCTION
2
PS
SUPPLEMENTATION THERAPY
NEUTROPENIA
4
PS
SUPPLEMENTATION THERAPY
THROMBOCYTOPENIA
4
PS
SUPPLEMENTATION THERAPY
WHITE BLOOD CELL COUNT DECREASED
4
PS
THYMOMA
ALOPECIA
6
PS
THYMOMA
HYPERTRANSAMINASAEMIA
6
PS
THYMOMA
NAUSEA
6
PS
THYMOMA
NEUTROPENIA
6
SS
ANTIEMETIC SUPPORTIVE CARE
DECREASED APPETITE
3
SS
ANTIEMETIC SUPPORTIVE CARE
MALAISE
3
SS
ANTIEMETIC SUPPORTIVE CARE
NEUTROPENIA
3
SS
ANTIEMETIC SUPPORTIVE CARE
PYREXIA
3
SS
ANTIEMETIC SUPPORTIVE CARE
WHITE BLOOD CELL COUNT DECREASED
3
SS
ASTHMA
URINARY TRACT INFECTION
1
SS
BONE PAIN
PANCYTOPENIA
1
SS
BREAST CANCER
ABDOMINAL PAIN UPPER
18
SS
BREAST CANCER
ACUTE MYELOID LEUKAEMIA
2
SS
BREAST CANCER
ALOPECIA
3
SS
BREAST CANCER
ANAEMIA
19
SS
BREAST CANCER
BLOOD DISORDER
4
SS
BREAST CANCER
CARDIAC ARREST
15
SS
BREAST CANCER
CARDIAC DISORDER
5
SS
BREAST CANCER
CARDIOMYOPATHY
5
SS
BREAST CANCER
CONFUSIONAL STATE
5
SS
BREAST CANCER
CONSTIPATION
3
SS
BREAST CANCER
CORONARY ARTERY DISEASE
10
SS
BREAST CANCER
DECREASED APPETITE
5
SS
BREAST CANCER
DIARRHOEA
3
SS
BREAST CANCER
DIZZINESS
5
SS
BREAST CANCER
DYSPNOEA
5
SS
BREAST CANCER
EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED
3
SS
BREAST CANCER
EMBOLISM
9
SS
BREAST CANCER
ENDOMETRIAL CANCER
10
SS
BREAST CANCER
EXTRAVASATION
9
SS
BREAST CANCER
FEBRILE NEUTROPENIA
5
SS
BREAST CANCER
GASTROINTESTINAL INFECTION
6
SS
BREAST CANCER
GLUCOSE TOLERANCE IMPAIRED
5
SS
BREAST CANCER
HAEMORRHAGE SUBCUTANEOUS
1
SS
BREAST CANCER
HEADACHE
5
SS
BREAST CANCER
HEMIPARESIS
5
SS
BREAST CANCER
HYPERALBUMINAEMIA
5
SS
BREAST CANCER
HYPERGLYCAEMIA
5
SS
BREAST CANCER
HYPERTRANSAMINASAEMIA
3
SS
BREAST CANCER
HYPOALBUMINAEMIA
10
SS
BREAST CANCER
HYPOTENSION
15
SS
BREAST CANCER
HYPOXIA
6
SS
BREAST CANCER
IMPAIRED HEALING
6
SS
BREAST CANCER
INFECTION
6
SS
BREAST CANCER
LEUKOPENIA
10
SS
BREAST CANCER
LUNG CANCER METASTATIC
1
SS
BREAST CANCER
LUNG INFECTION
15
SS
BREAST CANCER
MALAISE
2
SS
BREAST CANCER
MATERNAL EXPOSURE DURING PREGNANCY
10
SS
BREAST CANCER
MIXED LIVER INJURY
3
SS
BREAST CANCER
MUCOSAL INFLAMMATION
3
SS
BREAST CANCER
MYOCARDIAL INFARCTION
15
SS
BREAST CANCER
NAUSEA
10
SS
BREAST CANCER
NEUROPATHY PERIPHERAL
5
SS
BREAST CANCER
NEUTROPENIA
8
SS
BREAST CANCER
NEUTROPHIL COUNT DECREASED
15
SS
BREAST CANCER
OEDEMA
9
SS
BREAST CANCER
OPTIC ISCHAEMIC NEUROPATHY
5
SS
BREAST CANCER
OTITIS MEDIA
5
SS
BREAST CANCER
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME
8
SS
BREAST CANCER
PANCREATITIS
18
SS
BREAST CANCER
PANCYTOPENIA
4
SS
BREAST CANCER
PLATELET COUNT DECREASED
15
SS
BREAST CANCER
PNEUMONIA
9
SS
BREAST CANCER
PYREXIA
7
SS
BREAST CANCER
RESPIRATORY TRACT INFECTION
7
SS
BREAST CANCER
SARCOIDOSIS
5
SS
BREAST CANCER
SEPSIS
7
SS
BREAST CANCER
SKIN INFECTION
4
SS
BREAST CANCER
SKIN NECROSIS
9
SS
BREAST CANCER
STOMATITIS
3
SS
BREAST CANCER
SYNCOPE
11
SS
BREAST CANCER
THROMBOCYTOPENIA
3
SS
BREAST CANCER
TRANSAMINASES INCREASED
3
SS
BREAST CANCER
URINARY TRACT INFECTION
6
SS
BREAST CANCER
URTICARIA
3
SS
BREAST CANCER
VENTRICULAR ARRHYTHMIA
5
SS
BREAST CANCER
VOMITING
3
SS
BREAST CANCER
WHITE BLOOD CELL COUNT DECREASED
17
SS
BREAST CANCER METASTATIC
FEBRILE NEUTROPENIA
4
SS
BREAST CANCER RECURRENT
FEBRILE NEUTROPENIA
1
SS
BREAST CANCER RECURRENT
HYPERNATRAEMIA
1
SS
BREAST CANCER RECURRENT
MALAISE
1
SS
BREAST CANCER RECURRENT
NEOPLASM MALIGNANT
1
SS
BREAST CANCER RECURRENT
SEPTIC SHOCK
3
SS
CANCER PAIN
LEUKOPENIA
5
SS
CANCER PAIN
RESPIRATORY TRACT INFECTION
5
SS
CANCER PAIN
SEPSIS
5
SS
CHEMOTHERAPY
BILOMA
1
SS
CHEMOTHERAPY
CONDITION AGGRAVATED
1
SS
CHEMOTHERAPY
CONVULSION
1
SS
CHEMOTHERAPY
HEPATIC FAILURE
3
SS
CHEMOTHERAPY
HEPATIC NEOPLASM MALIGNANT
4
SS
CHEMOTHERAPY
NEOPLASM PROGRESSION
4
SS
CHEMOTHERAPY
OESOPHAGEAL VARICES HAEMORRHAGE
2
SS
CHEMOTHERAPY
OFF LABEL USE
5
SS
CHEMOTHERAPY
TUMOUR THROMBOSIS
4
SS
CONSTIPATION
BLOOD PRESSURE INCREASED
2
SS
CONSTIPATION
DECREASED APPETITE
2
SS
CONSTIPATION
DIARRHOEA
2
SS
CONSTIPATION
DYSPHONIA
2
SS
CONSTIPATION
HAEMORRHAGIC ASCITES
4
SS
CONSTIPATION
LIVER CARCINOMA RUPTURED
2
SS
CONSTIPATION
METASTASES TO PERITONEUM
2
SS
CONSTIPATION
THROMBOCYTOPENIA
2
SS
CONSTIPATION
URINARY TRACT INFECTION
1
SS
DEPRESSION
PANCYTOPENIA
2
SS
DYSPEPSIA
URINARY TRACT INFECTION
1
SS
GASTRIC CANCER
ABDOMINAL HERNIA
4
SS
GASTRIC CANCER
ABDOMINAL PAIN
3
SS
GASTRIC CANCER
BILE DUCT STENOSIS
3
SS
GASTRIC CANCER
BILIARY TRACT INFECTION
3
SS
GASTRIC CANCER
DEATH
4
SS
GASTRIC CANCER
DEHYDRATION
6
SS
GASTRIC CANCER
DEVICE OCCLUSION
3
SS
GASTRIC CANCER
DIARRHOEA
4
SS
GASTRIC CANCER
FATIGUE
3
SS
GASTRIC CANCER
FISTULA
3
SS
GASTRIC CANCER
GASTRIC PERFORATION
3
SS
GASTRIC CANCER
GENERAL PHYSICAL HEALTH DETERIORATION
3
SS
GASTRIC CANCER
HAEMOPTYSIS
4
SS
GASTRIC CANCER
HICCUPS
3
SS
GASTRIC CANCER
HYPERVENTILATION
6
SS
GASTRIC CANCER
IMPAIRED HEALING
4
SS
GASTRIC CANCER
MALAISE
3
SS
GASTRIC CANCER
MUCOSAL INFLAMMATION
3
SS
GASTRIC CANCER
NAUSEA
6
SS
GASTRIC CANCER
NEOPLASM MALIGNANT
3
SS
GASTRIC CANCER
NEUTROPENIA
3
SS
GASTRIC CANCER
NEUTROPENIC SEPSIS
8
SS
GASTRIC CANCER
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME
3
SS
GASTRIC CANCER
PULMONARY EMBOLISM
7
SS
GASTRIC CANCER
PYREXIA
6
SS
GASTRIC CANCER
VOMITING
6
SS
GASTRIC CANCER
WOUND DEHISCENCE
4
SS
GASTRIC CANCER
WOUND INFECTION
4
SS
GASTRITIS PROPHYLAXIS
HAEMORRHAGIC ASCITES
2
SS
GASTRITIS PROPHYLAXIS
LIVER CARCINOMA RUPTURED
1
SS
GASTRITIS PROPHYLAXIS
METASTASES TO PERITONEUM
1
SS
GASTROOESOPHAGEAL CANCER
IMPAIRED HEALING
4
SS
GASTROOESOPHAGEAL REFLUX DISEASE
PANCYTOPENIA
1
SS
HEPATIC CIRRHOSIS
CLOSTRIDIAL INFECTION
2
SS
HEPATIC CIRRHOSIS
LIVER ABSCESS
2
SS
HEPATIC FUNCTION ABNORMAL
BLOOD PRESSURE INCREASED
2
SS
HEPATIC FUNCTION ABNORMAL
DECREASED APPETITE
2
SS
HEPATIC FUNCTION ABNORMAL
DIARRHOEA
2
SS
HEPATIC FUNCTION ABNORMAL
DYSPHONIA
2
SS
HEPATIC FUNCTION ABNORMAL
THROMBOCYTOPENIA
2
SS
HEPATIC NEOPLASM MALIGNANT
BILIARY TRACT DISORDER
4
SS
HEPATIC NEOPLASM MALIGNANT
BILOMA
2
SS
HEPATIC NEOPLASM MALIGNANT
BLOOD CHLORIDE DECREASED
2
SS
HEPATIC NEOPLASM MALIGNANT
BLOOD PRESSURE INCREASED
2
SS
HEPATIC NEOPLASM MALIGNANT
BLOOD SODIUM DECREASED
2
SS
HEPATIC NEOPLASM MALIGNANT
CLOSTRIDIAL INFECTION
2
SS
HEPATIC NEOPLASM MALIGNANT
DECREASED APPETITE
2
SS
HEPATIC NEOPLASM MALIGNANT
DIARRHOEA
2
SS
HEPATIC NEOPLASM MALIGNANT
DYSPHONIA
2
SS
HEPATIC NEOPLASM MALIGNANT
HAEMORRHAGIC ASCITES
6
SS
HEPATIC NEOPLASM MALIGNANT
LIVER ABSCESS
2
SS
HEPATIC NEOPLASM MALIGNANT
LIVER CARCINOMA RUPTURED
3
SS
HEPATIC NEOPLASM MALIGNANT
METASTASES TO PERITONEUM
3
SS
HEPATIC NEOPLASM MALIGNANT
PLATELET COUNT DECREASED
2
SS
HEPATIC NEOPLASM MALIGNANT
THROMBOCYTOPENIA
2
SS
HEPATIC NEOPLASM MALIGNANT
WHITE BLOOD CELL COUNT DECREASED
2
SS
HOUSE DUST ALLERGY
URINARY TRACT INFECTION
1
SS
HYPERAMMONAEMIA
HAEMORRHAGIC ASCITES
2
SS
HYPERAMMONAEMIA
LIVER CARCINOMA RUPTURED
1
SS
HYPERAMMONAEMIA
METASTASES TO PERITONEUM
1
SS
HYPERTENSION
HAEMORRHAGIC ASCITES
2
SS
HYPERTENSION
LIVER CARCINOMA RUPTURED
1
SS
HYPERTENSION
METASTASES TO PERITONEUM
1
SS
ILEUS
PANCYTOPENIA
2
SS
INSOMNIA
HAEMORRHAGIC ASCITES
2
SS
INSOMNIA
LIVER CARCINOMA RUPTURED
1
SS
INSOMNIA
METASTASES TO PERITONEUM
1
SS
INSOMNIA
PANCYTOPENIA
3
SS
LEUKOPENIA
LEUKOPENIA
1
SS
LEUKOPENIA
RESPIRATORY TRACT INFECTION
1
SS
LEUKOPENIA
SEPSIS
1
SS
LIP DISORDER
LIVER ABSCESS
2
SS
LIP DISORDER
OFF LABEL USE
2
SS
METASTASES TO BONE
PANCYTOPENIA
2
SS
METASTASES TO LIVER
SEPTIC SHOCK
3
SS
METASTASES TO LUNG
SEPTIC SHOCK
3
SS
MUSCLE SPASMS
HAEMORRHAGIC ASCITES
4
SS
MUSCLE SPASMS
LIVER CARCINOMA RUPTURED
2
SS
MUSCLE SPASMS
METASTASES TO PERITONEUM
2
SS
MUSCULOSKELETAL PAIN
URINARY TRACT INFECTION
1
SS
NAUSEA
FEBRILE NEUTROPENIA
1
SS
NAUSEA
GENERAL PHYSICAL HEALTH DETERIORATION
2
SS
NAUSEA
NAUSEA
2
SS
NAUSEA
NEOPLASM MALIGNANT
2
SS
NAUSEA
PANCYTOPENIA
1
SS
NAUSEA
VOMITING
2
SS
NEOPLASM MALIGNANT
DEEP VEIN THROMBOSIS
3
SS
NEOPLASM MALIGNANT
EMBOLISM VENOUS
3
SS
NEOPLASM MALIGNANT
PULMONARY EMBOLISM
3
SS
NEUTROPENIA
FEBRILE NEUTROPENIA
1
SS
NEUTROPENIA
HYPERNATRAEMIA
1
SS
NEUTROPENIA
MALAISE
1
SS
NEUTROPENIA
NEOPLASM MALIGNANT
1
SS
NON-HODGKIN'S LYMPHOMA
MATERNAL EXPOSURE DURING PREGNANCY
22
SS
NON-HODGKIN'S LYMPHOMA STAGE IV
CARDIAC FAILURE
13
SS
NON-HODGKIN'S LYMPHOMA STAGE IV
DRUG EFFECT DECREASED
13
SS
NON-HODGKIN'S LYMPHOMA STAGE IV
REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA
13
SS
OFF LABEL USE
ALOPECIA
1
SS
OFF LABEL USE
HYPERTRANSAMINASAEMIA
1
SS
OFF LABEL USE
NAUSEA
1
SS
OFF LABEL USE
NEUTROPENIA
1
SS
PAIN
FEBRILE NEUTROPENIA
1
SS
PAIN
URINARY TRACT INFECTION
1
SS
PERCUTANEOUS ETHANOL INJECTION THERAPY
HEPATIC NEOPLASM MALIGNANT
1
SS
PERCUTANEOUS ETHANOL INJECTION THERAPY
NEOPLASM PROGRESSION
1
SS
PERCUTANEOUS ETHANOL INJECTION THERAPY
OFF LABEL USE
1
SS
PERCUTANEOUS ETHANOL INJECTION THERAPY
TUMOUR THROMBOSIS
1
SS
PORTAL HYPERTENSION
HAEMORRHAGIC ASCITES
2
SS
PORTAL HYPERTENSION
LIVER CARCINOMA RUPTURED
1
SS
PORTAL HYPERTENSION
METASTASES TO PERITONEUM
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
ABDOMINAL PAIN UPPER
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
ALOPECIA
9
SS
PRODUCT USED FOR UNKNOWN INDICATION
ANAEMIA
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD CREATININE INCREASED
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD DISORDER
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD UREA INCREASED
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
CARDIOMYOPATHY
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
CONFUSIONAL STATE
4
SS
PRODUCT USED FOR UNKNOWN INDICATION
CONSTIPATION
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
DEATH
6
SS
PRODUCT USED FOR UNKNOWN INDICATION
DIZZINESS
4
SS
PRODUCT USED FOR UNKNOWN INDICATION
DYSPNOEA
4
SS
PRODUCT USED FOR UNKNOWN INDICATION
EMBOLISM
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
GLUCOSE TOLERANCE IMPAIRED
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
HEADACHE
4
SS
PRODUCT USED FOR UNKNOWN INDICATION
HEMIPARESIS
4
SS
PRODUCT USED FOR UNKNOWN INDICATION
HYPERGLYCAEMIA
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
HYPERTRANSAMINASAEMIA
4
SS
PRODUCT USED FOR UNKNOWN INDICATION
LEUKOPENIA
13
SS
PRODUCT USED FOR UNKNOWN INDICATION
MIXED LIVER INJURY
11
SS
PRODUCT USED FOR UNKNOWN INDICATION
NAUSEA
5
SS
PRODUCT USED FOR UNKNOWN INDICATION
NEUTROPENIA
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
OFF LABEL USE
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
OLIGURIA
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
PANCREATITIS
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
RESPIRATORY TRACT INFECTION
13
SS
PRODUCT USED FOR UNKNOWN INDICATION
SEPSIS
13
SS
PRODUCT USED FOR UNKNOWN INDICATION
SKIN INFECTION
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
STOMATITIS
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
SYNCOPE
4
SS
PRODUCT USED FOR UNKNOWN INDICATION
TRANSAMINASES INCREASED
4
SS
PRODUCT USED FOR UNKNOWN INDICATION
TUMOUR LYSIS SYNDROME
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
URTICARIA
4
SS
PRODUCT USED FOR UNKNOWN INDICATION
VENTRICULAR ARRHYTHMIA
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
VOMITING
4
SS
PROPHYLAXIS
FEBRILE NEUTROPENIA
1
SS
PROPHYLAXIS
PANCYTOPENIA
1
SS
PROPHYLAXIS
URINARY TRACT INFECTION
1
SS
PSYCHOTHERAPY
FEBRILE NEUTROPENIA
1
SS
REGIONAL CHEMOTHERAPY
HEPATIC FAILURE
1
SS
REGIONAL CHEMOTHERAPY
HEPATIC NEOPLASM MALIGNANT
2
SS
REGIONAL CHEMOTHERAPY
NEOPLASM PROGRESSION
2
SS
REGIONAL CHEMOTHERAPY
OESOPHAGEAL VARICES HAEMORRHAGE
1
SS
REGIONAL CHEMOTHERAPY
OFF LABEL USE
2
SS
REGIONAL CHEMOTHERAPY
TUMOUR THROMBOSIS
2
SS
RESPIRATORY TRACT INFECTION
LEUKOPENIA
1
SS
RESPIRATORY TRACT INFECTION
RESPIRATORY TRACT INFECTION
1
SS
RESPIRATORY TRACT INFECTION
SEPSIS
1
SS
RHABDOMYOSARCOMA
CACHEXIA
7
SS
RHABDOMYOSARCOMA
DISEASE COMPLICATION
7
SS
RHABDOMYOSARCOMA
INFECTION
7
SS
RHABDOMYOSARCOMA
TOXICITY TO VARIOUS AGENTS
7
SS
SEPSIS
LEUKOPENIA
1
SS
SEPSIS
RESPIRATORY TRACT INFECTION
1
SS
SEPSIS
SEPSIS
1
SS
SLEEP DISORDER
URINARY TRACT INFECTION
1
SS
SUPPORTIVE CARE
GASTROINTESTINAL INFECTION
2
SS
THERAPEUTIC EMBOLISATION
BLOOD CREATININE INCREASED
1
SS
THERAPEUTIC EMBOLISATION
BLOOD PRESSURE INCREASED
4
SS
THERAPEUTIC EMBOLISATION
BLOOD UREA INCREASED
1
SS
THERAPEUTIC EMBOLISATION
DECREASED APPETITE
4
SS
THERAPEUTIC EMBOLISATION
DIALYSIS
3
SS
THERAPEUTIC EMBOLISATION
DIARRHOEA
4
SS
THERAPEUTIC EMBOLISATION
DYSPHONIA
4
SS
THERAPEUTIC EMBOLISATION
OFF LABEL USE
4
SS
THERAPEUTIC EMBOLISATION
OLIGURIA
1
SS
THERAPEUTIC EMBOLISATION
RENAL FAILURE
3
SS
THERAPEUTIC EMBOLISATION
THROMBOCYTOPENIA
4
SS
THERAPEUTIC EMBOLISATION
TUMOUR LYSIS SYNDROME
4
SS
THYMOMA
ALOPECIA
6
SS
THYMOMA
HYPERTRANSAMINASAEMIA
6
SS
THYMOMA
MALAISE
3
SS
THYMOMA
NAUSEA
3
SS
THYMOMA
NEUTROPENIA
6
C
BLOOD PRESSURE MANAGEMENT
HYPERTENSION
3
C
BLOOD PRESSURE MANAGEMENT
LIVER DISORDER
3
C
BREAST CANCER
ACUTE MYELOID LEUKAEMIA
1
C
BREAST CANCER
ANAEMIA
6
C
BREAST CANCER
BONE DENSITY INCREASED
12
C
BREAST CANCER
CARDIAC FAILURE
6
C
BREAST CANCER
CEREBELLAR INFARCTION
1
C
BREAST CANCER
CEREBRAL INFARCTION
6
C
BREAST CANCER
DISSEMINATED INTRAVASCULAR COAGULATION
6
C
BREAST CANCER
EXPOSED BONE IN JAW
12
C
BREAST CANCER
GINGIVAL SWELLING
12
C
BREAST CANCER
GINGIVITIS
12
C
BREAST CANCER
HAEMOGLOBIN DECREASED
12
C
BREAST CANCER
HAEMORRHAGE
2
C
BREAST CANCER
HYPOAESTHESIA
12
C
BREAST CANCER
INFUSION RELATED REACTION
1
C
BREAST CANCER
INTERSTITIAL LUNG DISEASE
6
C
BREAST CANCER
METASTASES TO LIVER
2
C
BREAST CANCER
METASTASES TO SKIN
2
C
BREAST CANCER
MORPHOEA
2
C
BREAST CANCER
MYOCARDIAL INFARCTION
12
C
BREAST CANCER
NAUSEA
9
C
BREAST CANCER
NEOPLASM MALIGNANT
1
C
BREAST CANCER
OSTEOMYELITIS
12
C
BREAST CANCER
PAIN
12
C
BREAST CANCER
PALATITIS
12
C
BREAST CANCER
PURULENT DISCHARGE
12
C
BREAST CANCER
RED BLOOD CELL COUNT DECREASED
12
C
BREAST CANCER
RENAL IMPAIRMENT
2
C
BREAST CANCER
SCLERODERMA
2
C
BREAST CANCER
SCLERODERMA RENAL CRISIS
4
C
BREAST CANCER
TOOTHACHE
12
C
BREAST CANCER
VOMITING
9
C
BREAST CANCER METASTATIC
C-REACTIVE PROTEIN INCREASED
1
C
BREAST CANCER METASTATIC
NEUTROPHIL COUNT DECREASED
1
C
BREAST CANCER METASTATIC
WHITE BLOOD CELL COUNT DECREASED
1
C
GASTRITIS PROPHYLAXIS
NAUSEA
1
C
GASTRITIS PROPHYLAXIS
VOMITING
1
C
HEPATIC NEOPLASM MALIGNANT
ALANINE AMINOTRANSFERASE INCREASED
2
C
HEPATIC NEOPLASM MALIGNANT
ANAEMIA
2
C
HEPATIC NEOPLASM MALIGNANT
ASPARTATE AMINOTRANSFERASE INCREASED
2
C
HEPATIC NEOPLASM MALIGNANT
BLOOD LACTATE DEHYDROGENASE INCREASED
2
C
HEPATIC NEOPLASM MALIGNANT
BLOOD PRESSURE DECREASED
2
C
HEPATIC NEOPLASM MALIGNANT
C-REACTIVE PROTEIN INCREASED
2
C
HEPATIC NEOPLASM MALIGNANT
CONSTIPATION
2
C
HEPATIC NEOPLASM MALIGNANT
DECREASED APPETITE
2
C
HEPATIC NEOPLASM MALIGNANT
DEHYDRATION
2
C
HEPATIC NEOPLASM MALIGNANT
DIARRHOEA
2
C
HEPATIC NEOPLASM MALIGNANT
DIVERTICULITIS
2
C
HEPATIC NEOPLASM MALIGNANT
DIZZINESS
2
C
HEPATIC NEOPLASM MALIGNANT
EOSINOPHIL COUNT INCREASED
2
C
HEPATIC NEOPLASM MALIGNANT
GAIT DISTURBANCE
2
C
HEPATIC NEOPLASM MALIGNANT
HYPERTENSION
3
C
HEPATIC NEOPLASM MALIGNANT
HYPOALBUMINAEMIA
2
C
HEPATIC NEOPLASM MALIGNANT
LIVER DISORDER
3
C
HEPATIC NEOPLASM MALIGNANT
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME
2
C
HEPATIC NEOPLASM MALIGNANT
PLATELET COUNT DECREASED
2
C
HEPATIC NEOPLASM MALIGNANT
WHITE BLOOD CELL COUNT DECREASED
2
C
HEPATIC NEOPLASM MALIGNANT
WHITE BLOOD CELL COUNT INCREASED
2
C
HYPERTENSION
HAEMORRHAGE
2
C
HYPERTENSION
METASTASES TO LIVER
2
C
HYPERTENSION
METASTASES TO SKIN
2
C
HYPERTENSION
MORPHOEA
2
C
HYPERTENSION
RENAL IMPAIRMENT
2
C
HYPERTENSION
SCLERODERMA
2
C
HYPERTENSION
SCLERODERMA RENAL CRISIS
4
C
METASTASES TO BONE
ANAEMIA
1
C
METASTASES TO BONE
APHAGIA
1
C
METASTASES TO BONE
BONE DENSITY INCREASED
2
C
METASTASES TO BONE
BONE LESION
1
C
METASTASES TO BONE
C-REACTIVE PROTEIN INCREASED
1
C
METASTASES TO BONE
DENTAL FISTULA
1
C
METASTASES TO BONE
EXPOSED BONE IN JAW
3
C
METASTASES TO BONE
GINGIVAL ABSCESS
1
C
METASTASES TO BONE
GINGIVAL SWELLING
2
C
METASTASES TO BONE
GINGIVITIS
2
C
METASTASES TO BONE
HAEMOGLOBIN DECREASED
2
C
METASTASES TO BONE
HYPOAESTHESIA
2
C
METASTASES TO BONE
HYPOPHAGIA
1
C
METASTASES TO BONE
MOUTH HAEMORRHAGE
1
C
METASTASES TO BONE
MUCOSAL ULCERATION
1
C
METASTASES TO BONE
MYOCARDIAL INFARCTION
2
C
METASTASES TO BONE
NEOPLASM MALIGNANT
1
C
METASTASES TO BONE
NEOPLASM PROGRESSION
1
C
METASTASES TO BONE
ORAL DISORDER
1
C
METASTASES TO BONE
ORAL INFECTION
1
C
METASTASES TO BONE
ORAL MUCOSAL ERYTHEMA
1
C
METASTASES TO BONE
ORAL TORUS
1
C
METASTASES TO BONE
OSTEOMYELITIS
3
C
METASTASES TO BONE
OSTEONECROSIS OF JAW
1
C
METASTASES TO BONE
PAIN
3
C
METASTASES TO BONE
PAIN IN JAW
1
C
METASTASES TO BONE
PALATITIS
2
C
METASTASES TO BONE
PRIMARY SEQUESTRUM
1
C
METASTASES TO BONE
PURULENT DISCHARGE
2
C
METASTASES TO BONE
RED BLOOD CELL COUNT DECREASED
2
C
METASTASES TO BONE
SOFT TISSUE INFECTION
1
C
METASTASES TO BONE
STOMATITIS
1
C
METASTASES TO BONE
SWELLING
1
C
METASTASES TO BONE
TOOTH ABSCESS
1
C
METASTASES TO BONE
TOOTHACHE
2
C
METASTASES TO BONE
WHITE BLOOD CELL COUNT INCREASED
1
C
METASTASES TO BONE
WOUND COMPLICATION
1
C
MINERAL SUPPLEMENTATION
NAUSEA
2
C
MINERAL SUPPLEMENTATION
VOMITING
2
C
PAIN
HAEMORRHAGE
3
C
PAIN
METASTASES TO LIVER
3
C
PAIN
METASTASES TO SKIN
3
C
PAIN
MORPHOEA
3
C
PAIN
RENAL IMPAIRMENT
3
C
PAIN
SCLERODERMA
3
C
PAIN
SCLERODERMA RENAL CRISIS
5
C
PRODUCT USED FOR UNKNOWN INDICATION
CEREBELLAR INFARCTION
4
C
PRODUCT USED FOR UNKNOWN INDICATION
INFUSION RELATED REACTION
4
C
PROPHYLAXIS OF NAUSEA AND VOMITING
NAUSEA
7
C
PROPHYLAXIS OF NAUSEA AND VOMITING
VOMITING
7
C
THERAPEUTIC EMBOLISATION
ALANINE AMINOTRANSFERASE INCREASED
4
C
THERAPEUTIC EMBOLISATION
ANAEMIA
4
C
THERAPEUTIC EMBOLISATION
ASPARTATE AMINOTRANSFERASE INCREASED
4
C
THERAPEUTIC EMBOLISATION
BLOOD LACTATE DEHYDROGENASE INCREASED
4
C
THERAPEUTIC EMBOLISATION
BLOOD PRESSURE DECREASED
4
C
THERAPEUTIC EMBOLISATION
C-REACTIVE PROTEIN INCREASED
4
C
THERAPEUTIC EMBOLISATION
CONSTIPATION
4
C
THERAPEUTIC EMBOLISATION
DECREASED APPETITE
4
C
THERAPEUTIC EMBOLISATION
DEHYDRATION
4
C
THERAPEUTIC EMBOLISATION
DIARRHOEA
4
C
THERAPEUTIC EMBOLISATION
DIVERTICULITIS
4
C
THERAPEUTIC EMBOLISATION
DIZZINESS
4
C
THERAPEUTIC EMBOLISATION
EOSINOPHIL COUNT INCREASED
4
C
THERAPEUTIC EMBOLISATION
GAIT DISTURBANCE
4
C
THERAPEUTIC EMBOLISATION
HYPOALBUMINAEMIA
4
C
THERAPEUTIC EMBOLISATION
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME
4
C
THERAPEUTIC EMBOLISATION
PLATELET COUNT DECREASED
4
C
THERAPEUTIC EMBOLISATION
WHITE BLOOD CELL COUNT DECREASED
4
C
THERAPEUTIC EMBOLISATION
WHITE BLOOD CELL COUNT INCREASED
4
Ads by Google